Molecular techniques for identifying HCC origin and biology after orthotopic liver transplantation

Diagnostic Molecular Pathology

Volumn 15, Issue 2, 2006, Pages 90-94

  Mas, Valeria R ^a   Maluf, Daniel G ^a   Dumur, Catherine I ^a   Archer, Kellie J ^a   Yanek, Kenneth ^a   Jackson Cook, Colleen ^a   Fisher, Robert A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatocellular carcinoma; Microarrays; Short tandem repeat

Indexed keywords

COMPLEMENTARY DNA; RNA; AMELOGENIN; DNA; ENAMEL PROTEIN;

ADULT; ANAMNESIS; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; CHROMOSOME ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DNA POLYMORPHISM; DNA PROBE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE AMPLIFICATION; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RNA ISOLATION; SHORT TANDEM REPEAT; TRANSCRIPTION INITIATION; TUMOR BIOPSY; DNA MICROARRAY; DONOR; FEMALE; GENE EXPRESSION PROFILING; GENETICS; LIVER TUMOR; MIDDLE AGED; SECOND CANCER; TANDEM REPEAT; TUMOR RECURRENCE;

AMELOGENIN; CARCINOMA, HEPATOCELLULAR; DENTAL ENAMEL PROTEINS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; TANDEM REPEAT SEQUENCES; TISSUE DONORS;

EID: 33746441192     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200606000-00005     Document Type: Article

References (19)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. New Engl J Med. 1999;340:745-750.
3. Maluf D, Fisher RA, Maroney T, et al. Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy. Am J Transplant. 2003;3:312-317.
4. Fisher RA, Maroney TP, Fulcher AS, et al. Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation. Clin Transplant. 2002;16(Suppl 7):52-58.
5. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479-490.
6. Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transplant. 2004;10:534-540.
7. Khakhar A, Solano E, Stell D, et al. Survival after liver transplantation for hepatocellular carcinoma. Transplant Proc. 2003;35:2438-2441.
8. Altimari A, Gruppioni E, Fiorentino M, et al. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation. Diagn Mol Pathol. 2005:14:34-38.
9. Lee JS, Chu IS, Heo J, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004;40:667-676.
10. Mas V, Maluf D, Thomson M, et al. Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis. Cell Transplantation 2004;3:231-236.
11. Jenkins RB, Qian J, Lee HK, et al. A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res. 1998;58:759-766.
12. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
13. Radmacher MD, McShane LM, Simon R. A paradigm for class prediction using gene expression profiles. Biometric Research Branch, National Cancer Institute. J Comput Biol. 2002;9:505-511.
14. Li C, Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2001;2:RESEARCH0032.
15. Saxena R, Ye MQ, Emre S, et al. De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transplant Surg. 1999;5:81-82.
16. Glanzer JG, Eberwine JH. Expression profiling of small cellular samples in cancer: less is more. Br J Cancer. 2004;90:1111-1114.
17. Altimari A, Gruppioni E, Fiorentino M, et al. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation. Diagn Mol Pathol. 2005;14:34-38.
18. Lones MA, Lopez-Terrada D, Weiss LM, et al. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med. 1997;121:701-706.
19. Hove WR, van Hoek B, Bajema IM, et al. Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytes. Liver Transplant. 2003;9:552-556.